In summary, in this study we bring evidence that N-cadherin upregulation in prostate cancer cells appears to result from the binding of AR variants to AREs in intron 1 of the CDH2 gene followed by histone H4 acetylation, but also from a decrease of endogenous AR-FL. Here, AR is linked to prostate cancer.